{
  "id": 1022,
  "text": "[J].Gynecol Oncol, 2013, 130(2):264-268.[61] GARLAND S M, PAAVONEN J, JAISAMRARN U, et al.Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial[J].",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: [J].Gynecol Oncol, 2013, 130(2):264-268.[61] GARLAND S M, PAAVONEN J, JAISAMRARN U, et al.Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial[J].\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据研究内容，HPV-16/18 AS04佐剂疫苗可以减少宫颈上皮内瘤变（CIN）术后复发的风险。研究表明，先前接种此类疫苗的患者在接受宫颈上皮内瘤变的手术治疗后，复发高等级CIN（如CIN2或CIN3）的风险显著降低。这种预防效果可能与疫苗增强针对HPV 16/18型的免疫反应有关，从而减少残留或重新感染病毒导致的复发风险。",
  "query": "根据提供的 <text> 内容，相关研究提到 HPV（人乳头瘤病毒）疫苗与宫颈上皮瘤的关系，因此问题如下：  \n\n接种HPV-16/18 AS04佐剂疫苗是否能够减少宫颈上皮内瘤变术后复发的风险？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据提供的 <text> 内容，相关研究提到 HPV（人乳头瘤病毒）疫苗与宫颈上皮瘤的关系，因此问题如下：  \n\n接种HPV-16/18 AS04佐剂疫苗是否能够减少宫颈上皮内瘤变术后复发的风险？\n\n<reference text>: [J].Gynecol Oncol, 2013, 130(2):264-268.[61] GARLAND S M, PAAVONEN J, JAISAMRARN U, et al.Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial[J].\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据研究内容，HPV-16/18 AS04佐剂疫苗可以减少宫颈上皮内瘤变（CIN）术后复发的风险。研究表明，先前接种此类疫苗的患者在接受宫颈上皮内瘤变的手术治疗后，复发高等级CIN（如CIN2或CIN3）的风险显著降低。这种预防效果可能与疫苗增强针对HPV 16/18型的免疫反应有关，从而减少残留或重新感染病毒导致的复发风险。"
}